Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 14(1): e0209573, 2019.
Article in English | MEDLINE | ID: mdl-30608949

ABSTRACT

Glycosaminoglycans (GAGs), including heparan sulfates and chondroitin sulfates, are major components of the extracellular matrix. Upon interacting with heparin binding growth factors (HBGF), GAGs participate to the maintaintenance of tissue homeostasis and contribute to self-healing. Although several processes regulated by HBGF are altered in Alzheimer's disease, it is unknown whether the brain GAG capacities to bind and regulate the function of HBGF or of other heparin binding proteins, as tau, are modified in this disease. Here, we show that total sulfated GAGs from hippocampus of Alzheimer's disease have altered capacities to bind and potentiate the activities of growth factors including FGF-2, VEGF, and BDNF while their capacity to bind to tau is remarkable increased. Alterations of GAG structures and capacities to interact with and regulate the activity of heparin binding proteins might contribute to impaired tissue homeostasis in the Alzheimer's disease brain.


Subject(s)
Alzheimer Disease/metabolism , Glycosaminoglycans/metabolism , tau Proteins/physiology , Aged , Aged, 80 and over , Brain/metabolism , Brain-Derived Neurotrophic Factor/metabolism , Brazil , Chondroitin Sulfates/metabolism , Extracellular Matrix/metabolism , Female , Fibroblast Growth Factor 2/metabolism , Heparin/metabolism , Heparitin Sulfate/metabolism , Hippocampus/metabolism , Humans , Male , Middle Aged , Protein Binding , Temporal Lobe/metabolism , Vascular Endothelial Growth Factor A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...